U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 4,732 records

Showing results for "secondary".

  1. Nrd 2011 Maskedstats Core V2 Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2_Weighted.PDF
    January 01, 2011 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 2,225 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 9,019 0.02% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 100,535 … 0.27% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 8,504 0.02% 849: RADIOTHERAPY … 0.11% 40: Multiple myeloma 18,762 0.05% 41: Cancer; other and unspecified primary 8,065 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  2. Nrd 2010 Maskedstats Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Core_V2.PDF
    January 01, 2010 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 986 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 4,109 0.03% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 41,377 … 0.30% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 3,518 0.03% 849: RADIOTHERAPY … 0.11% 40: Multiple myeloma 7,525 0.05% 41: Cancer; other and unspecified primary 3,016 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  3. Nrd 2010 Maskedstats Core V2 Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Core_V2_Weighted.PDF
    January 01, 2010 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 2,437 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 10,023 0.03% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 103,217 … 0.28% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 7,920 0.02% 849: RADIOTHERAPY … 0.11% 40: Multiple myeloma 18,475 0.05% 41: Cancer; other and unspecified primary 7,842 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  4. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/mk-eb9VtB_jx885wnjuzk3
    January 01, 2024 - placebo or no statin on health outcomes in adults without prior CVD events (full list of primary and secondary … consistent with those from recent systematic reviews, some of which also included trials of statins for secondary … prevention.47,51-53 Similar to other meta-analyses of primary and secondary prevention trials,54,55 … cataracts (OR, 0.81 [95% CI, 0.71 to 0.93]).59 In contrast with systematic reviews of primary and secondary … Other analy- ses that included secondary prevention trials also suggested an as- sociation between higher

  5. EPC Methods: An Exploration of Methods and Context for the Production of Rapid Reviews (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
    February 01, 2015 - secondary sources varied: three products reported including systematic reviews and HTAs and one product … rapid response products apply a best evidence approach and report the results of primary studies if no secondary … Health: Clinical Evidence.”19 This product presents a list of the publications available, organized by secondary … Three preferentially looked for existing systematic reviews or HTAs, one never included secondary studies … • Reliance on secondary sources: Many organizations relied on existing systematic reviews or HTA reports

  6. Introduction to the NIS (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2022.pdf
    November 01, 2024 - and data elements that are not uniformly available across States, such as AHA hospital identifiers, secondary … data elements that were not available uniformly across the States, such as hospital identifiers, secondary … procedure information ICD-10-CM diagnoses I10_DX1 – I10_DX40 ICD-10-CM diagnoses, principal and secondary … Name Coding Notes ICD-10-PCS procedures I10_PR1 – I10_PR25 ICD-10-PCS procedures, principal and secondary … of days from admission to principal procedure PRDAY2 – PRDAY25 Number of days from admission to secondary

  7. Maskedstats Nrd 2015Q1Q3 Dx Pr Grps (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Dx_Pr_Grps.PDF
    October 31, 2017 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 601 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 5,272 0.04% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 34,050 … 0.26% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 1,814 0.01% 849: RADIOTHERAPY … 0.11% 40: Multiple myeloma 7,302 0.06% 41: Cancer; other and unspecified primary 2,557 0.02% 42: Secondary … disease) 26,176 0.20% 98: Essential hypertension 19,541 0.15% 99: Hypertension with complications and secondary

  8. Maskedstats Nis 2015Q1Q3 Dx Pr Grps (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Dx_Pr_Grps.PDF
    November 08, 2017 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 237 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 2,123 0.04% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 13,751 … Distribution for DRG_NOPOA DRG_NoPOA Frequency Percent of Total 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 0.11% 40: Multiple myeloma 2,715 0.05% 41: Cancer; other and unspecified primary 1,151 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  9. Nis 2013 Maskedstats Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Core_Weighted.PDF
    January 01, 2013 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,905 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 11,425 0.03% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 98,005 … 0.28% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 6,765 0.02% please … 0.11% 40: Multiple myeloma 18,040 0.05% 41: Cancer; other and unspecified primary 7,230 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  10. Nis 2012 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Core.PDF
    January 01, 2012 - W OTHER O.R.PROC 1,126 0.02% 409: RADIOTHERAPY 566 0.01% 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 26,601 0.36% 464: SIGNS & SYMPTOMS W/O CC 6,766 0.09% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 148 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 1,743 0.02% 467 … 0.11% 40: Multiple myeloma 3,687 0.05% 41: Cancer; other and unspecified primary 1,480 0.02% 42: Secondary … disease) 14,189 0.19% 98: Essential hypertension 12,992 0.18% 99: Hypertension with complications and secondary

  11. AHRQ Safety Program for Perinatal Care: Establishing a Program of In Situ Simulations (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/situ/simulation_facguide.pdf
    May 01, 2017 - the facilitator should remind participants that the focus is primarily on team performance, with a secondary

  12. Learn From Defects in Care of Mechanically Ventilated Patients: Facilitator Guide | Agency for Healthcare Research and Quality

    www.ahrq.gov/hai/tools/mvp/modules/cusp/learn-from-defects-fac-guide.html
    February 01, 2017 - Identify any new information and secondary defects introduced by the intervention.

  13. In Conversation With… Kaveh Shojania, MD | PSNet

    psnet.ahrq.gov/perspective/conversation-kaveh-shojania-md
    February 26, 2025 - So I recommend some combination of finding the right secondary source—in this case PSNet—and following

  14. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/50754/psn-pdf
    December 18, 2019 - The Case A 63-year-old woman with a history of liver transplantation secondary to hepatitis C, low back

  15. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33748/psn-pdf
    April 01, 2013 - very reliable both at the level of the initial review by hospital-based reviewers as well as at the secondary

  16. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/72613/psn-pdf
    December 22, 2020 - When I first joined the School of Dentistry in 2007, there was a need to put that data together for secondary

  17. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33873/psn-pdf
    February 01, 2019 - quaternary every day, and we're partnering with other organizations where more of our primary and secondary

  18. References (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/ltvv-litreview.docx
    January 01, 2017 - Secondary outcomes were the development of ALI, duration of mechanical ventilation, and mortality. … Secondary endpoints included the proportion of patients extubated at 6 hours and indices of lung mechanics

  19. Low Tidal Volume (Lung Protective) Ventilation Literature Review | Agency for Healthcare Research and Quality

    www.ahrq.gov/hai/tools/mvp/modules/technical/ltvv-lit-review.html
    January 01, 2017 - Secondary outcomes were the development of ALI, duration of mechanical ventilation, and mortality. … Secondary endpoints included the proportion of patients extubated at 6 hours and indices of lung mechanics

  20. Final Progress Report: Helping Elders Include Quality in Health Plan Choice (pdf file)

    www.ahrq.gov/sites/default/files/2024-07/uhrig-report.pdf
    January 01, 2024 - Employers are the secondary audience, as the intermediaries that decide to invest in this system to … Medicare and their employer’s health insurance, specifically that the employer health insurance plan was secondary
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (1196)

hcup-us.ahrq.gov (1163)

effectivehealthcare.ahrq.gov (808)

www.ahrq.gov (695)

digital.ahrq.gov (428)

www.uspreventiveservicestaskforce.org (380)

cds.ahrq.gov (21)

cdsic.ahrq.gov (16)

integrationacademy.ahrq.gov (8)

meps.ahrq.gov (7)

datatools.ahrq.gov (4)

qualityindicators.ahrq.gov (4)

pso.ahrq.gov (2)